Nivea Men Protective

Product NDC
10356-566
11-digit product format
103560566
Labeler code
10356
Product ID
10356-566_f126c8a0-2f2a-7a45-e053-2a95a90ad13e
Type
HUMAN OTC DRUG
Nonproprietary name
Avobenzone, Octisalate, Octocrylene
Dosage form
LOTION
Route
TOPICAL
Labeler
Beiersdorf Inc
Application
part352
Marketing category
OTC MONOGRAPH NOT FINAL
Marketing start
2015-11-01
Marketing end
2024-07-01
Substance
AVOBENZONE; OCTISALATE; OCTOCRYLENE
Active strength
3 g/100mL; g/100mL; g/100mL
NDC exclude flag
No
Listing certified through
0000-00-00
Current FDA listing
Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 2 matching rows.

Dataset, Scope, Product NDC table
DatasetScopeProduct NDCPackage NDCCodeStatusReporting periodSource date
excluded productproduct10356-566DDiscontinued by firm2026-10-15
excluded packagepackage10356-56610356-566-16DDiscontinued by firm2026-10-15

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 24 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source dateDatasetScopePackage NDCSnapshotSource SHA-256
2025-12-14 17:58 UTC · source 2025-12-05excluded productproductd630ba8d3edf…732f749b63fb…
2025-12-14 17:58 UTC · source 2025-12-05excluded packagepackage10356-566-16d630ba8d3edf…732f749b63fb…
2025-08-27 00:01 UTC · source 2025-08-26excluded productproductf5e01cc5f278…a2eaf40c39c3…
2025-08-27 00:01 UTC · source 2025-08-26excluded packagepackage10356-566-16f5e01cc5f278…a2eaf40c39c3…
2025-04-01 02:39 UTC · source 2025-03-31excluded productproduct2ef7874e63bc…57b86245f4fa…
2025-04-01 02:39 UTC · source 2025-03-31excluded packagepackage10356-566-162ef7874e63bc…57b86245f4fa…
2025-03-28 20:22 UTC · source 2025-03-28excluded productproducta1b67e2a42f9…c4cf2c586c0d…
2025-03-28 20:22 UTC · source 2025-03-28excluded packagepackage10356-566-16a1b67e2a42f9…c4cf2c586c0d…
2025-03-22 03:12 UTC · source 2025-03-21excluded productproductcfe11265f3b6…090c488252e2…
2025-03-22 03:12 UTC · source 2025-03-21excluded packagepackage10356-566-16cfe11265f3b6…090c488252e2…
2025-03-10 12:48 UTC · source 2025-03-10excluded productproductcdf11ea48f46…ba0047e9e063…
2025-03-10 12:48 UTC · source 2025-03-10excluded packagepackage10356-566-16cdf11ea48f46…ba0047e9e063…
2025-02-02 03:52 UTC · source 2025-01-31excluded productproduct302b2466d912…e7b80fea0513…
2025-02-02 03:52 UTC · source 2025-01-31excluded packagepackage10356-566-16302b2466d912…e7b80fea0513…
2025-01-20 13:05 UTC · source 2025-01-20excluded productproducted331223b511…672a5bd82f5f…
2025-01-20 13:05 UTC · source 2025-01-20excluded packagepackage10356-566-16ed331223b511…672a5bd82f5f…
2025-01-11 03:41 UTC · source 2025-01-10excluded productproduct0efc9e666f02…f202fb6c5f17…
2025-01-11 03:41 UTC · source 2025-01-10excluded packagepackage10356-566-160efc9e666f02…f202fb6c5f17…
2024-11-09 02:27 UTC · source 2024-11-08excluded productproductad56d346431e…cc804d4bbf1e…
2024-11-09 02:27 UTC · source 2024-11-08excluded packagepackage10356-566-16ad56d346431e…cc804d4bbf1e…
2024-10-04 04:10 UTC · source 2024-10-03excluded productproduct367a005e9d99…383a685ebd0f…
2024-10-04 04:10 UTC · source 2024-10-03excluded packagepackage10356-566-16367a005e9d99…383a685ebd0f…
2024-07-10 04:00 UTC · source 2024-07-09excluded productproduct557ba5c1ecfa…9c80585c8c6e…
2024-07-10 04:00 UTC · source 2024-07-09excluded packagepackage10356-566-16557ba5c1ecfa…9c80585c8c6e…

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
AVOBENZONEACTIVE INGREDIENTG63QQF2NOXNIVEA MEN PROTECTIVE (AVOBENZONE, OCTISALATE, OCTOCRYLENE) LOTION [BEIERSDORF INC]1
OCTISALATEACTIVE INGREDIENT4X49Y0596WNIVEA MEN PROTECTIVE (AVOBENZONE, OCTISALATE, OCTOCRYLENE) LOTION [BEIERSDORF INC]1
OCTOCRYLENEACTIVE INGREDIENT5A68WGF6WMNIVEA MEN PROTECTIVE (AVOBENZONE, OCTISALATE, OCTOCRYLENE) LOTION [BEIERSDORF INC]1
AVOBENZONEACTIVE MOIETYG63QQF2NOXNIVEA MEN PROTECTIVE (AVOBENZONE, OCTISALATE, OCTOCRYLENE) LOTION [BEIERSDORF INC]1
OCTISALATEACTIVE MOIETY4X49Y0596WNIVEA MEN PROTECTIVE (AVOBENZONE, OCTISALATE, OCTOCRYLENE) LOTION [BEIERSDORF INC]1
OCTOCRYLENEACTIVE MOIETY5A68WGF6WMNIVEA MEN PROTECTIVE (AVOBENZONE, OCTISALATE, OCTOCRYLENE) LOTION [BEIERSDORF INC]1
.ALPHA.-TOCOPHEROL ACETATE, DL-INACTIVE INGREDIENTWR1WPI7EW8NIVEA MEN PROTECTIVE (AVOBENZONE, OCTISALATE, OCTOCRYLENE) LOTION [BEIERSDORF INC]1
1,2-HEXANEDIOLINACTIVE INGREDIENTTR046Y3K1GNIVEA MEN PROTECTIVE (AVOBENZONE, OCTISALATE, OCTOCRYLENE) LOTION [BEIERSDORF INC]1
ALCOHOLINACTIVE INGREDIENT3K9958V90MNIVEA MEN PROTECTIVE (AVOBENZONE, OCTISALATE, OCTOCRYLENE) LOTION [BEIERSDORF INC]1
ALOEINACTIVE INGREDIENTV5VD430YW9NIVEA MEN PROTECTIVE (AVOBENZONE, OCTISALATE, OCTOCRYLENE) LOTION [BEIERSDORF INC]1
CARBOMER HOMOPOLYMER TYPE C (ALLYL PENTAERYTHRITOL CROSSLINKED)INACTIVE INGREDIENT4Q93RCW27ENIVEA MEN PROTECTIVE (AVOBENZONE, OCTISALATE, OCTOCRYLENE) LOTION [BEIERSDORF INC]1
CARBOMER INTERPOLYMER TYPE A (ALLYL SUCROSE CROSSLINKED)INACTIVE INGREDIENT59TL3WG5CONIVEA MEN PROTECTIVE (AVOBENZONE, OCTISALATE, OCTOCRYLENE) LOTION [BEIERSDORF INC]1
CETOSTEARYL ALCOHOLINACTIVE INGREDIENT2DMT128M1SNIVEA MEN PROTECTIVE (AVOBENZONE, OCTISALATE, OCTOCRYLENE) LOTION [BEIERSDORF INC]1
EDETATE TRISODIUMINACTIVE INGREDIENT420IP921MBNIVEA MEN PROTECTIVE (AVOBENZONE, OCTISALATE, OCTOCRYLENE) LOTION [BEIERSDORF INC]1
ETHYLHEXYLGLYCERININACTIVE INGREDIENT147D247K3PNIVEA MEN PROTECTIVE (AVOBENZONE, OCTISALATE, OCTOCRYLENE) LOTION [BEIERSDORF INC]1
GLYCERININACTIVE INGREDIENTPDC6A3C0OXNIVEA MEN PROTECTIVE (AVOBENZONE, OCTISALATE, OCTOCRYLENE) LOTION [BEIERSDORF INC]1
GLYCERYL STEARATE CITRATEINACTIVE INGREDIENTWH8T92A065NIVEA MEN PROTECTIVE (AVOBENZONE, OCTISALATE, OCTOCRYLENE) LOTION [BEIERSDORF INC]1
ISOPROPYL PALMITATEINACTIVE INGREDIENT8CRQ2TH63MNIVEA MEN PROTECTIVE (AVOBENZONE, OCTISALATE, OCTOCRYLENE) LOTION [BEIERSDORF INC]1
PANTHENOLINACTIVE INGREDIENTWV9CM0O67ZNIVEA MEN PROTECTIVE (AVOBENZONE, OCTISALATE, OCTOCRYLENE) LOTION [BEIERSDORF INC]1
PHENOXYETHANOLINACTIVE INGREDIENTHIE492ZZ3TNIVEA MEN PROTECTIVE (AVOBENZONE, OCTISALATE, OCTOCRYLENE) LOTION [BEIERSDORF INC]1
SODIUM HYDROXIDEINACTIVE INGREDIENT55X04QC32INIVEA MEN PROTECTIVE (AVOBENZONE, OCTISALATE, OCTOCRYLENE) LOTION [BEIERSDORF INC]1
STARCH, TAPIOCAINACTIVE INGREDIENT24SC3U704INIVEA MEN PROTECTIVE (AVOBENZONE, OCTISALATE, OCTOCRYLENE) LOTION [BEIERSDORF INC]1
WATERINACTIVE INGREDIENT059QF0KO0RNIVEA MEN PROTECTIVE (AVOBENZONE, OCTISALATE, OCTOCRYLENE) LOTION [BEIERSDORF INC]1

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
10356-566-161035605661675 mL in 1 TUBE (10356-566-16) 75 ml2015-11-010000-00-00NoNoCurrent